Pamela W. Montgomery, who serves as Chief Legal Officer-Healthcare at Nutex Health Inc. (NASDAQ:NUTX), executed an open-market purchase of company common stock on March 13, 2026. Montgomery acquired 79 shares at $88.87 per share, for a total consideration of $7,020.
The trade occurred against a backdrop of recent weakness in the stock - shares had fallen nearly 10% over the prior week and were trading roughly 49% below their 52-week high of $193.07 at the time of the purchase.
Separately, Montgomery reported another transaction on March 10, 2026, involving 1,523 Restricted Stock Units (RSUs). Combining these filings, Montgomery now holds 2,758 shares of Nutex Health common stock directly and 4,441 Restricted Stock Units.
Valuation note: An InvestingPro analysis referenced in reports states the stock appears undervalued at the then-current price, with shares trading below Fair Value. That analysis is tied to a Pro Research Report available for this and more than 1,400 other US-listed equities.
Company performance: Nutex Health disclosed a pronounced revenue decline for the fourth quarter of 2025, with total revenue down 41.1% compared with the same period a year earlier. The quarterly shortfall has generated investor concern despite commentary that the company produced an overall strong full-year performance.
The sharp quarterly revenue contraction and the recent share-price weakness have prompted closer attention from analysts and market participants, who are monitoring Nutex Health's financial trajectory and any strategic responses management may pursue. The company’s ability to restore revenue momentum was highlighted as a focus for stakeholders following the release.
Montgomery's purchase adds insider buying to the list of recent developments. While the investment increases her direct stake modestly, the transactions also coincide with the firm's challenged quarter and a valuation assessment that indicates shares were trading below Fair Value at the reported levels.
No additional details regarding future insider transactions, management plans or operational changes were disclosed in the filings reporting these trades.